C07D 317/64
Oxygen atoms
C07D317/64 (Oxygen atoms) appears on 238 US grants and 166 published applications in this corpus.
Search patents in C07D- Granted patents
- 238
- Published applications
- 166
- Assignees
- 179
- Inventors
- 808
- Latest grant
- 9 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 15 | 0 |
| 1977 | 7 | 0 |
| 1978 | 2 | 0 |
| 1979 | 8 | 0 |
| 1980 | 5 | 0 |
| 1981 | 14 | 0 |
| 1982 | 6 | 0 |
| 1983 | 1 | 0 |
| 1984 | 4 | 0 |
| 1985 | 3 | 0 |
| 1986 | 0 | 0 |
| 1987 | 3 | 0 |
| 1988 | 2 | 0 |
| 1989 | 3 | 0 |
| 1990 | 4 | 0 |
| 1991 | 6 | 0 |
| 1992 | 1 | 0 |
| 1993 | 5 | 0 |
| 1994 | 3 | 0 |
| 1995 | 2 | 0 |
| 1996 | 3 | 0 |
| 1997 | 4 | 0 |
| 1998 | 4 | 0 |
| 1999 | 3 | 0 |
| 2000 | 6 | 0 |
| 2001 | 7 | 5 |
| 2002 | 9 | 8 |
| 2003 | 9 | 7 |
| 2004 | 6 | 6 |
| 2005 | 2 | 6 |
| 2006 | 6 | 13 |
| 2007 | 5 | 8 |
| 2008 | 3 | 5 |
| 2009 | 6 | 6 |
| 2010 | 5 | 5 |
| 2011 | 2 | 9 |
| 2012 | 3 | 5 |
| 2013 | 5 | 5 |
| 2014 | 6 | 5 |
| 2015 | 0 | 6 |
| 2016 | 3 | 4 |
| 2017 | 2 | 1 |
| 2018 | 5 | 10 |
| 2019 | 7 | 7 |
| 2020 | 4 | 16 |
| 2021 | 11 | 9 |
| 2022 | 6 | 6 |
| 2023 | 4 | 2 |
| 2024 | 3 | 6 |
| 2025 | 5 | 3 |
| 2026 | 0 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Substituted ethylamine fused heterocyclic mescaline derivatives9 Dec 2025US 12,492,179 B2Enveric Biosciences Canada Inc.
- Method of therapeutically treating cancer25 Nov 2025US 12,479,813 B2ADT Pharmaceuticals, LLC
- Fused heterocyclic mescaline derivatives30 Sep 2025US 12,428,408 B2Enveric Biosciences Canada Inc.
- Inhibitors of meprin α and β5 Aug 2025US 12,378,186 B2Vivoryon Therapeutics N.V.
- Compositions and methods for viral sensitization14 Jan 2025US 12,195,451 B2Ottawa Hospital Research Institute and University of Ottawa
- 3-[(benzo[d][1,3]dioxolane-4-yl)oxy]propylamine hydrochloride, optical isomer and crystal thereof, and preparation method therefor3 Sep 2026US 2026/0258009 A1Jiangsu Nhwa Pharmaceutical Co., Ltd
- Aryl thioethers as hif-2alpha inhibitors2 Jul 2026US 2026/0184676 A1Hoffmann-La Roche Inc.
- Substituted ethylamine fused heterocyclic mescaline derivatives5 Mar 2026US 2026/0062399 A1Enveric Biosciences Canada Inc.
- Radiation-sensitive composition, method for forming resist pattern, and compound30 Oct 2025US 2025/0334880 A1Jsr Corporation
- Modulators of the integrated stress pathway17 Apr 2025US 2025/0122188 A1AbbVie Inc.
Most cited
By later US patents
- Substituted semicarbazides and the use thereof155US 6,281,211 B1Euro-Celtique S. A. · 2001
- Benzenesulfonamides and benzamides as therapeutic agents114US 6,583,161 B1Tularik Inc. · 2003
- Substituted 2-aminoacetamides and the use thereof101US 6,500,825 B2Euro-Celtique S. A. · 2002
- Benzenesulfonamides and benzamides as therapeutic agents94US 6,191,170 B1Tularik Inc. · 2001
- Carbazolyl-(4)-oxypropanolamine compounds and therapeutic compositions82US 4,503,067 ABoehringer Mannheim GmbH · 1985